Pulmonary carcinosarcoma showing an obvious response to pazopanib: a case report
Abstract Background Pulmonary carcinosarcoma (PCS) is a rare primary lung malignancy and has a poor prognosis among lung tumor histological subtypes. However, an appropriate treatment strategy has not been developed for unresectable PCS. Case presentation A 65-year-old man who was diagnosed with PCS...
Main Authors: | Azusa Tanimoto, Shinji Takeuchi, Hiroshi Kotani, Kaname Yamashita, Tadaaki Yamada, Koushiro Ohtsubo, Hiromichi Ebi, Hiroko Ikeda, Seiji Yano |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12890-018-0757-7 |
Similar Items
-
Gastric carcinosarcoma with FGFR2 amplification under long-term control with pazopanib: a case report and literature review
by: Hirokatsu Hayashi, et al.
Published: (2022-07-01) -
Sinonasal Teratoid Carcinosarcoma
by: Jose M. Carnate
Published: (2007-11-01) -
Insights into Clinical Features and Outcomes of Adrenal Cortical Carcinosarcoma
by: Zachery Branham, et al.
Published: (2022-10-01) -
Breast Carcinosarcomas
by: Savaş Yakan, et al.
Published: (2014-07-01) -
Clinical activity of pazopanib in metastatic extraosseous Ewing sarcoma
by: Steven Attia, et al.
Published: (2015-05-01)